Regulation
In Rescheduling Comments, Cannabis Regulators Offer Support, Ask for Clarity, and Share Experiences
Individual state governors and the National Conference of State Legislatures shared support, too.
In Rescheduling Comments, Transport, Safety, and Alcohol Groups Spotlight Impairment Concerns
Major groups like AAA and the National Transportation Safety Board commented on cannabis rescheduling.
Cannabis Rescheduling Comments: What Did Justice, Law Enforcement, Labor, and Religious Groups Say?
The Center for American Progress, the Southern Baptist Convention, and the United Food and Commercial Workers International Union submitted comments.
Medical and Research Groups Call for Funding, Clarity on Synthetics Cannabinoids in Rescheduling Comments
The American Medical Association, the University of California system, and the Epilepsy Foundation submitted comments.
Federal Agencies Continue To Work on Cannabis Policy, From Standards to Research
An excerpt from the Cannabis Wire Daily newsletter.
U.S. Standards Agency Releases Material to Help Labs Distinguish “Marijuana” From “Hemp”
An excerpt from the Cannabis Wire Daily newsletter.
Who’s Calling for a Hearing on Rescheduling?
An excerpt from the Cannabis Wire Daily newsletter.
Pres. Biden Formally Announces DOJ Will Move to Reclassify Cannabis
Now, the public will have a chance to weigh in on cannabis rescheduling.
In Historic Move, DEA Will Recommend Cannabis Reclassification
The rescheduling of cannabis, once complete, will mark an historic shift in U.S. cannabis policy, and is likely to send ripple effects across the globe.
OSHA Officials Lay Out Cannabis Workplace Safety Landscape
Even though cannabis remains federally illegal, that hasn’t stopped OSHA officials from collecting data on potential workplace safety hazards in the nascent industry.
House Lawmakers Push Top FDA Official on Hemp Products and Cannabis Rescheduling
The conversation covered the proliferation of intoxicating hemp products, as well as the timeline for the federal review of whether to move cannabis from Schedule I to III.
FDA Officials Discuss Future of Cannabis Regulation at Food & Drug Law Institute
The conversation ranged from Congressional inaction on CBD to the myriad unregulated cannabinoid products on shelves today.
Cannabis Regulators Work to Forge a Path on Interstate Commerce
States along the west coast have already passed laws to allow for “controlled” interstate commerce – when federal law changes.
What Else Is In HHS’ Cannabis Rescheduling Docs?
Many groups’ work, from CANNRA to the National Academies of Sciences, Engineering, and Medicine, informed a federal recommendation to reclassify cannabis.
State Medical Cannabis Programs, Booming Research, Informed HHS Recommendation to Reclassify Cannabis
Newly released documents from the Dept. of Health and Human Services detail the agency’s recommendation to the DEA to put cannabis in Schedule III.
National Academies’ Cannabis Committee Convenes Again
The second meeting of the Committee on the Public Health Consequences of Changes in the Cannabis Policy Landscape is underway this week. Here’s what happened on day one.
